Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bos, IGAC; van Mierlo, GJ; Bleeker, WK; Rigter, GMM; Velthuis, HT; Dickneite, G; Hack, CE
   The potentiation of human C1-inhibitor by dextran sulphate is transient invivo: studies in a rat model
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   I.G.A.C. Bos et al., "The potentiation of human C1-inhibitor by dextran sulphate is transient invivo: studies in a rat model", INT IMMUNO, 1(8), 2001, pp. 1583-1595
2. Bowen, B; Hawk, JJ; Sibunka, S; Hovick, S; Weiler, JM
   A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations
   CLINICAL IMMUNOLOGY
   
   B. Bowen et al., "A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations", CLIN IMMUNO, 98(2), 2001, pp. 157-163
3. Shernan, SK; Collard, CD
   Role of the complement system in ischaemic heart disease - Potential for pharmacological intervention
   BIODRUGS
   
   S.K. Shernan e C.D. Collard, "Role of the complement system in ischaemic heart disease - Potential for pharmacological intervention", BIODRUGS, 15(9), 2001, pp. 595-607
4. Tassani, P; Kunkel, R; Richter, JA; Oechsler, H; Lorenz, HP; Braun, SL; Eising, GP; Haas, F; Paek, SU; Bauernschmitt, R; Jochum, M; Lange, R
   Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates
   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
   
   P. Tassani et al., "Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates", J CARDIOTHO, 15(4), 2001, pp. 469-473
5. Lamark, T; Ingebrigtsen, M; Bjornstad, C; Melkko, T; Mollnes, TE; Nielsen, EW
   Expression of active human C1 inhibitor serpin domain in Escherichia coli
   PROTEIN EXPRESSION AND PURIFICATION
   
   T. Lamark et al., "Expression of active human C1 inhibitor serpin domain in Escherichia coli", PROT EX PUR, 22(2), 2001, pp. 349-358
6. Farkas, H; Harmat, G; Kaposi, PN; Karadi, I; Fekete, B; Fust, G; Fay, K; Vass, A; Varga, L
   Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema
   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
   
   H. Farkas et al., "Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema", EUR J GASTR, 13(10), 2001, pp. 1225-1230
7. Vangerow, B; Hafner, D; Rueckoldt, H; Marx, G; Ott, N; Leuwer, M; Frerking, I; Germann, PG
   Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histologyin rats with lavage-induced acute lung injury
   INTENSIVE CARE MEDICINE
   
   B. Vangerow et al., "Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histologyin rats with lavage-induced acute lung injury", INTEN CAR M, 27(9), 2001, pp. 1526-1531
8. Stiller, B; Sonntag, J; Dahnert, I; Alexi-Meskishvili, V; Hetzer, R; Fischer, T; Lange, PE
   Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor
   INTENSIVE CARE MEDICINE
   
   B. Stiller et al., "Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor", INTEN CAR M, 27(1), 2001, pp. 193-200
9. Kirschfink, M
   Targeting complement in therapy
   IMMUNOLOGICAL REVIEWS
   
   M. Kirschfink, "Targeting complement in therapy", IMMUNOL REV, 180, 2001, pp. 177-189
10. Di Stefano, R; De Santis, M; Bergamaschini, L; Gobbo, G; Mosca, F
    C1-inhibitor protects human endothelial cell metabolic activity from prolonged cold storage
    TRANSPLANTATION PROCEEDINGS
    
    R. Di Stefano et al., "C1-inhibitor protects human endothelial cell metabolic activity from prolonged cold storage", TRANSPLAN P, 33(3), 2001, pp. 2269-2270
11. Farkas, H; Szongoth, M; Bely, M; Varga, L; Fekete, B; Karadi, I; Fust, G
    Angiooedema due to acquired deficiency of C1-esterase inhibitor associatedwith leucocytoclastic vasculitis
    ACTA DERMATO-VENEREOLOGICA
    
    H. Farkas et al., "Angiooedema due to acquired deficiency of C1-esterase inhibitor associatedwith leucocytoclastic vasculitis", ACT DER-VEN, 81(4), 2001, pp. 298-300
12. Braganza, JM
    Mast cell: pivotal player in lethal acute pancreatitis
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    J.M. Braganza, "Mast cell: pivotal player in lethal acute pancreatitis", QJM-MON J A, 93(7), 2000, pp. 469-476
13. Asghar, SS; Pasch, MC
    Therapeutic inhibition of the complement system. Y2K update
    FRONTIERS IN BIOSCIENCE
    
    S.S. Asghar e M.C. Pasch, "Therapeutic inhibition of the complement system. Y2K update", FRONT BIOSC, 5, 2000, pp. E63-E82A
14. O'Neil, KM
    Complement deficiency
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    
    K.M. O'Neil, "Complement deficiency", CL R ALL IM, 19(2), 2000, pp. 83-108
15. Klima, U; Kutschka, I; Warnecke, G; Kim, P; Struber, M; Kirschfink, M; Haverich, A
    Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    U. Klima et al., "Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models", EUR J CAR-T, 18(3), 2000, pp. 321-327
16. Fronhoffs, S; Luyken, J; Steuer, K; Hansis, M; Vetter, H; Walger, P
    The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients
    INTENSIVE CARE MEDICINE
    
    S. Fronhoffs et al., "The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients", INTEN CAR M, 26(10), 2000, pp. 1566-1570
17. Abumiya, T; Sakata, T; Enjyoji, K; Kato, H; Kawai, J; Suzuki, T; Masuda, J; Sasaguri, T; Ogata, J
    Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?
    JOURNAL OF HYPERTENSION
    
    T. Abumiya et al., "Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?", J HYPERTENS, 18(7), 2000, pp. 901-909
18. Sahu, A; Lambris, JD
    Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
    IMMUNOPHARMACOLOGY
    
    A. Sahu e J.D. Lambris, "Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics", IMMUNOPHARM, 49(1-2), 2000, pp. 133-148
19. Caliezi, C; Wuillemin, WA; Zeerleder, S; Redondo, M; Eisele, B; Hack, CE
    C1-esterase inhibitor: An anti-inflammatory agent and its potential use inthe treatment of diseases other than hereditary angioedema
    PHARMACOLOGICAL REVIEWS
    
    C. Caliezi et al., "C1-esterase inhibitor: An anti-inflammatory agent and its potential use inthe treatment of diseases other than hereditary angioedema", PHARM REV, 52(1), 2000, pp. 91-112
20. Sonntag, J; Stiller, B
    Systemic capillary leak syndrome in childhood
    MONATSSCHRIFT KINDERHEILKUNDE
    
    J. Sonntag e B. Stiller, "Systemic capillary leak syndrome in childhood", MONATS KIND, 148(3), 2000, pp. 220-228
21. Ninomiya, H; Kawashima, Y; Nagasawa, T
    Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H. Ninomiya et al., "Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin", BR J HAEM, 109(4), 2000, pp. 875-881
22. Markovic, SN; Inwards, DJ; Frigas, EA; Phyliky, RP
    Acquired C1 esterase inhibitor deficiency
    ANNALS OF INTERNAL MEDICINE
    
    S.N. Markovic et al., "Acquired C1 esterase inhibitor deficiency", ANN INT MED, 132(2), 2000, pp. 144-150
23. Collard, CD; Vakeva, A; Morrissey, MA; Agah, A; Rollins, SA; Reenstra, WR; Buras, JA; Meri, S; Stahl, GL
    Complement activation after oxidative stress - Role of the lectin complement pathway
    AMERICAN JOURNAL OF PATHOLOGY
    
    C.D. Collard et al., "Complement activation after oxidative stress - Role of the lectin complement pathway", AM J PATH, 156(5), 2000, pp. 1549-1556
24. Harten, P; Korbacher, D; Renk, C; Euler, HH; Loffler, H
    Hereditary angioedema. False diagnosis and therapy as systemic lupus erythematosus
    MEDIZINISCHE KLINIK
    
    P. Harten et al., "Hereditary angioedema. False diagnosis and therapy as systemic lupus erythematosus", MED KLIN, 94(6), 1999, pp. 339-344
25. Marx, G; Nashan, B; Meyer, MC; Vangerow, B; Schlitt, HJ; Ziesing, S; Leuwer, M; Piepenbrock, S; Rueckoldt, H
    Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor
    INTENSIVE CARE MEDICINE
    
    G. Marx et al., "Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor", INTEN CAR M, 25(9), 1999, pp. 1017-1020
26. Struber, M; Hagl, C; Hirt, SW; Cremer, J; Harringer, W; Haverich, A
    C1-esterase inhibitor in graft failure after lung transplantation
    INTENSIVE CARE MEDICINE
    
    M. Struber et al., "C1-esterase inhibitor in graft failure after lung transplantation", INTEN CAR M, 25(11), 1999, pp. 1315-1318
27. Kirschfink, M; Nurnberger, W
    C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application
    MOLECULAR IMMUNOLOGY
    
    M. Kirschfink e W. Nurnberger, "C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application", MOL IMMUNOL, 36(4-5), 1999, pp. 225-232
28. Collard, CD; Lekowski, R; Jordan, JE; Agah, A; Stahl, GL
    Complement activation following oxidative stress
    MOLECULAR IMMUNOLOGY
    
    C.D. Collard et al., "Complement activation following oxidative stress", MOL IMMUNOL, 36(13-14), 1999, pp. 941-948
29. Giebler, R; Schmidt, U; Koch, S; Peters, J; Scherer, R
    Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin
    CRITICAL CARE MEDICINE
    
    R. Giebler et al., "Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin", CRIT CARE M, 27(3), 1999, pp. 597-604
30. Fossum, S; Hoem, NO; Gjonnaess, H; Briseid, K
    Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy
    THROMBOSIS RESEARCH
    
    S. Fossum et al., "Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy", THROMB RES, 93(4), 1999, pp. 161-170
31. Zeerleder, S; Caliezi, C; Redondo, M; Devay, J; Wuillemin, WA
    Activation of the plasmatic cascade systems in sepsis: role of C1-inhibitor
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    
    S. Zeerleder et al., "Activation of the plasmatic cascade systems in sepsis: role of C1-inhibitor", SCHW MED WO, 129(39), 1999, pp. 1410-1417
32. Schneider, DT; Nurnberger, W; Stannigel, H; Bonig, H; Gobel, U
    Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitorconcentrate after haematopoietic stem cell transplantation
    GUT
    
    D.T. Schneider et al., "Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitorconcentrate after haematopoietic stem cell transplantation", GUT, 45(5), 1999, pp. 733-736
33. Heimann, A; Takeshima, T; Horstick, G; Kempski, O
    C1-esterase inhibitor reduces infarct volume after cortical vein occlusion
    BRAIN RESEARCH
    
    A. Heimann et al., "C1-esterase inhibitor reduces infarct volume after cortical vein occlusion", BRAIN RES, 838(1-2), 1999, pp. 210-213
34. Sonntag, J; Wagner, MH; Liu, GS; Vogel, M; Walka, MM; Maier, RF
    Effect of C1-inhibitor in a rat model of necrotizing enterocolitis
    BIOLOGY OF THE NEONATE
    
    J. Sonntag et al., "Effect of C1-inhibitor in a rat model of necrotizing enterocolitis", BIOL NEONAT, 76(4), 1999, pp. 235-241
35. Buerke, M; Ruprecht, HJ; vom Dahl, J; Terres, W; Seyfarth, M; Schultheiss, HP; Richardt, G; Sheehan, FH; Drexler, H
    Sodium-hydrogen exchange inhibition: Novel strategy to prevent myocardial injury following ischemia and reperfusion
    AMERICAN JOURNAL OF CARDIOLOGY
    
    M. Buerke et al., "Sodium-hydrogen exchange inhibition: Novel strategy to prevent myocardial injury following ischemia and reperfusion", AM J CARD, 83(10A), 1999, pp. 19G-22G
36. SUN ZW; WANG XD; DENG XM; LASSON A; WALLEN R; HALLBERG E; ANDERSSON R
    THE INFLUENCE OF INTESTINAL ISCHEMIA AND REPERFUSION ON BIDIRECTIONALINTESTINAL BARRIER PERMEABILITY, CELLULAR MEMBRANE INTEGRITY, PROTEINASE-INHIBITORS, AND CELL-DEATH IN RATS
    Shock
    
    Z.W. Sun et al., "THE INFLUENCE OF INTESTINAL ISCHEMIA AND REPERFUSION ON BIDIRECTIONALINTESTINAL BARRIER PERMEABILITY, CELLULAR MEMBRANE INTEGRITY, PROTEINASE-INHIBITORS, AND CELL-DEATH IN RATS", Shock, 10(3), 1998, pp. 203-212
37. Emeis, M; Sonntag, J; Willam, C; Strauss, E; Walka, MM; Obladen, M
    Acidosis activates complement system in vitro
    MEDIATORS OF INFLAMMATION
    
    M. Emeis et al., "Acidosis activates complement system in vitro", MEDIAT INFL, 7(6), 1998, pp. 417-420
38. NISSEN MH; BREGENHOLT S; HORDING JA; CLAESSON MH
    C1-ESTERASE INHIBITOR BLOCKS T-LYMPHOCYTE PROLIFERATION AND CYTOTOXICT-LYMPHOCYTE GENERATION IN-VITRO
    International immunology
    
    M.H. Nissen et al., "C1-ESTERASE INHIBITOR BLOCKS T-LYMPHOCYTE PROLIFERATION AND CYTOTOXICT-LYMPHOCYTE GENERATION IN-VITRO", International immunology, 10(2), 1998, pp. 167-173
39. Gerencer, M; Burek, V; Crowe, BA; Barrett, NP; Dorner, F
    The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients
    MICROBIAL PATHOGENESIS
    
    M. Gerencer et al., "The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients", MICROB PATH, 25(5), 1998, pp. 253-266
40. BAUERNSCHMITT R; BOHRER H; HAGL S
    RESCUE THERAPY WITH C1-ESTERASE INHIBITOR CONCENTRATE AFTER EMERGENCYCORONARY SURGERY FOR FAILED PTCA
    Intensive care medicine
    
    R. Bauernschmitt et al., "RESCUE THERAPY WITH C1-ESTERASE INHIBITOR CONCENTRATE AFTER EMERGENCYCORONARY SURGERY FOR FAILED PTCA", Intensive care medicine, 24(6), 1998, pp. 635-638
41. HEYING R; NURNBERGER W; SPIEKERKOTTER U; GOBEL U
    HEPATIC VENOOCCLUSIVE DISEASE WITH SEVERE CAPILLARY LEAKAGE AFTER PERIPHERAL STEM-CELL TRANSPLANTATION - TREATMENT WITH RECOMBINANT PLASMINOGEN-ACTIVATOR AND C1-ESTERASE INHIBITOR CONCENTRATE
    Bone marrow transplantation
    
    R. Heying et al., "HEPATIC VENOOCCLUSIVE DISEASE WITH SEVERE CAPILLARY LEAKAGE AFTER PERIPHERAL STEM-CELL TRANSPLANTATION - TREATMENT WITH RECOMBINANT PLASMINOGEN-ACTIVATOR AND C1-ESTERASE INHIBITOR CONCENTRATE", Bone marrow transplantation, 21(9), 1998, pp. 947-949
42. MANJI HH; SCOTT WE
    GENERAL ANESTHETIC FOR A PILONIDAL-SINUS EXCISION IN A PATIENT WITH HEREDITARY ANGIO-EDEMA
    European journal of anaesthesiology
    
    H.H. Manji e W.E. Scott, "GENERAL ANESTHETIC FOR A PILONIDAL-SINUS EXCISION IN A PATIENT WITH HEREDITARY ANGIO-EDEMA", European journal of anaesthesiology, 15(5), 1998, pp. 607-609
43. VLEEMING W; VANAMSTERDAM JGC; STRICKER BHC; DEWILDT DJ
    ACE INHIBITOR-INDUCED ANGIOEDEMA - INCIDENCE, PREVENTION AND MANAGEMENT
    Drug safety
    
    W. Vleeming et al., "ACE INHIBITOR-INDUCED ANGIOEDEMA - INCIDENCE, PREVENTION AND MANAGEMENT", Drug safety, 18(3), 1998, pp. 171-188
44. SANCHEZ J; ELGUE G; RIESENFELD J; OLSSON P
    STUDIES OF ADSORPTION, ACTIVATION, AND INHIBITION OF FACTOR-XII ON IMMOBILIZED HEPARIN
    Thrombosis research
    
    J. Sanchez et al., "STUDIES OF ADSORPTION, ACTIVATION, AND INHIBITION OF FACTOR-XII ON IMMOBILIZED HEPARIN", Thrombosis research, 89(1), 1998, pp. 41-50
45. JANSEN PM; EISELE B; DEJONG IW; CHANG A; DELVOS U; TAYLOR FB; HACK CE
    EFFECT OF CL INHIBITOR ON INFLAMMATORY AND PHYSIOLOGICAL-RESPONSE PATTERNS IN PRIMATES SUFFERING FROM LETHAL SEPTIC SHOCK
    The Journal of immunology
    
    P.M. Jansen et al., "EFFECT OF CL INHIBITOR ON INFLAMMATORY AND PHYSIOLOGICAL-RESPONSE PATTERNS IN PRIMATES SUFFERING FROM LETHAL SEPTIC SHOCK", The Journal of immunology, 160(1), 1998, pp. 475-484
46. GORING HD; BORK K; SPATH PJ; BAUER R; ZIEMER A; HINTNER H; WUTHRICH B
    HEREDITARY ANGIOEDEMA IN THE GERMAN-SPEAK ING REGION
    Hautarzt
    
    H.D. Goring et al., "HEREDITARY ANGIOEDEMA IN THE GERMAN-SPEAK ING REGION", Hautarzt, 49(2), 1998, pp. 114-122
47. YASOJIMA K; SCHWAB C; MCGEER EG; MCGEER PL
    HUMAN HEART GENERATES COMPLEMENT PROTEINS THAT ARE UP-REGULATED AND ACTIVATED AFTER MYOCARDIAL-INFARCTION
    Circulation research
    
    K. Yasojima et al., "HUMAN HEART GENERATES COMPLEMENT PROTEINS THAT ARE UP-REGULATED AND ACTIVATED AFTER MYOCARDIAL-INFARCTION", Circulation research, 83(8), 1998, pp. 860-869
48. VEERHUIS R; JANSSEN I; HOOZEMANS JJM; DEGROOT CJA; HACK CE; EIKELENBOOM P
    COMPLEMENT C1-INHIBITOR EXPRESSION IN ALZHEIMERS-DISEASE
    Acta Neuropathologica
    
    R. Veerhuis et al., "COMPLEMENT C1-INHIBITOR EXPRESSION IN ALZHEIMERS-DISEASE", Acta Neuropathologica, 96(3), 1998, pp. 287-296
49. MEALY K; CLOONEY A; MARKS P; HENNESSY T; JACKSON J
    EFFECTS OF ANABOLIC-STEROIDS ON ACUTE-PHASE RESPONSES IN INTRAABDOMINAL SEPSIS
    Mediators of inflammation
    
    K. Mealy et al., "EFFECTS OF ANABOLIC-STEROIDS ON ACUTE-PHASE RESPONSES IN INTRAABDOMINAL SEPSIS", Mediators of inflammation, 6(1), 1997, pp. 69-72
50. NURNBERGER W; HEYING R; BURDACH S; GOBEL U
    C1 ESTERASE INHIBITOR CONCENTRATE FOR CAPILLARY LEAKAGE SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION
    Annals of hematology
    
    W. Nurnberger et al., "C1 ESTERASE INHIBITOR CONCENTRATE FOR CAPILLARY LEAKAGE SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION", Annals of hematology, 75(3), 1997, pp. 95-101
51. LEITHAUSER B; MATTHIAS FR
    MICROCIRCULATION AND HEMOSTASIS IN INFLAM MATORY PROCESSES
    Medizinische Klinik
    
    B. Leithauser e F.R. Matthias, "MICROCIRCULATION AND HEMOSTASIS IN INFLAM MATORY PROCESSES", Medizinische Klinik, 92(7), 1997, pp. 426-431
52. MIKKONEN R; ARONEN HJ; KIVISAARI L; PIILONEN A; SYRJALA M
    PLASMA-LEVELS OF PREKALLIKREIN, ALPHA-2-MACROGLOBULIN AND C1-ESTERASEINHIBITOR IN PATIENTS WITH URTICARIAL REACTION TO CONTRAST-MEDIA
    Acta radiologica
    
    R. Mikkonen et al., "PLASMA-LEVELS OF PREKALLIKREIN, ALPHA-2-MACROGLOBULIN AND C1-ESTERASEINHIBITOR IN PATIENTS WITH URTICARIAL REACTION TO CONTRAST-MEDIA", Acta radiologica, 38(3), 1997, pp. 466-473
53. ZURAW BL
    URTICARIA, ANGIOEDEMA, AND AUTOIMMUNITY
    Clinics in laboratory medicine
    
    B.L. Zuraw, "URTICARIA, ANGIOEDEMA, AND AUTOIMMUNITY", Clinics in laboratory medicine, 17(3), 1997, pp. 559
54. VELTHUIS HT; BAUFRETON C; JANSEN PGM; THIJS CM; HACK CE; STURK A; WILDEVUUR CRH; LOISANCE DY
    HEPARIN COATING OF EXTRACORPOREAL CIRCUITS INHIBITS CONTACT ACTIVATION DURING CARDIAC OPERATIONS
    Journal of thoracic and cardiovascular surgery
    
    H.T. Velthuis et al., "HEPARIN COATING OF EXTRACORPOREAL CIRCUITS INHIBITS CONTACT ACTIVATION DURING CARDIAC OPERATIONS", Journal of thoracic and cardiovascular surgery, 114(1), 1997, pp. 117-122
55. WUILLEMIN WA; VELTHUIS HT; LUBBERS YTP; DERUIG CP; ELDERING E; HACK CE
    POTENTIATION OF C1 INHIBITOR BY GLYCOSAMINOGLYCANS - DEXTRAN SULFATE SPECIES ARE EFFECTIVE INHIBITORS OF IN-VITRO COMPLEMENT ACTIVATION IN PLASMA
    The Journal of immunology
    
    W.A. Wuillemin et al., "POTENTIATION OF C1 INHIBITOR BY GLYCOSAMINOGLYCANS - DEXTRAN SULFATE SPECIES ARE EFFECTIVE INHIBITORS OF IN-VITRO COMPLEMENT ACTIVATION IN PLASMA", The Journal of immunology, 159(4), 1997, pp. 1953-1960
56. YAMAGUCHI H; WEIDENBACH H; LUHRS H; LERCH MM; DICKNEITE G; ADLER G
    COMBINED TREATMENT WITH C1 ESTERASE INHIBITOR AND ANTITHROMBIN-III IMPROVES SURVIVAL IN SEVERE ACUTE EXPERIMENTAL PANCREATITIS
    Gut
    
    H. Yamaguchi et al., "COMBINED TREATMENT WITH C1 ESTERASE INHIBITOR AND ANTITHROMBIN-III IMPROVES SURVIVAL IN SEVERE ACUTE EXPERIMENTAL PANCREATITIS", Gut, 40(4), 1997, pp. 531-535
57. SABROE RA; BLACK AK
    ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS AND ANGIO-EDEMA
    British journal of dermatology
    
    R.A. Sabroe e A.K. Black, "ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS AND ANGIO-EDEMA", British journal of dermatology, 136(2), 1997, pp. 153-158
58. PATSTON PA; SCHAPIRA M
    REGULATION OF C1-INHIBITOR FUNCTION BY BINDING TO TYPE-IV COLLAGEN AND HEPARIN
    Biochemical and biophysical research communications
    
    P.A. Patston e M. Schapira, "REGULATION OF C1-INHIBITOR FUNCTION BY BINDING TO TYPE-IV COLLAGEN AND HEPARIN", Biochemical and biophysical research communications, 230(3), 1997, pp. 597-601
59. NIELSEN EW; GRAN JT; STRAUME B; MELLBYE OJ; JOHANSEN HT; MOLLNES TE
    HEREDITARY ANGIO-EDEMA - NEW CLINICAL OBSERVATIONS AND AUTOIMMUNE SCREENING, COMPLEMENT AND KALLIKREIN-KININ ANALYSES
    Journal of internal medicine
    
    E.W. Nielsen et al., "HEREDITARY ANGIO-EDEMA - NEW CLINICAL OBSERVATIONS AND AUTOIMMUNE SCREENING, COMPLEMENT AND KALLIKREIN-KININ ANALYSES", Journal of internal medicine, 239(2), 1996, pp. 119-130
60. FAWAZESTRUP F
    HUMAN PARVOVIRUS INFECTION - RHEUMATIC MANIFESTATIONS, ANGIOEDEMA, C1ESTERASE INHIBITOR DEFICIENCY, ANA POSITIVITY, AND POSSIBLE ONSET OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    Journal of rheumatology
    
    F. Fawazestrup, "HUMAN PARVOVIRUS INFECTION - RHEUMATIC MANIFESTATIONS, ANGIOEDEMA, C1ESTERASE INHIBITOR DEFICIENCY, ANA POSITIVITY, AND POSSIBLE ONSET OF SYSTEMIC LUPUS-ERYTHEMATOSUS", Journal of rheumatology, 23(7), 1996, pp. 1180-1185
61. ARMBRUST T; RAMADORI G
    FUNCTIONAL-CHARACTERIZATION OF 2 DIFFERENT KUPFFER CELL-POPULATIONS OF NORMAL RAT-LIVER
    Journal of hepatology
    
    T. Armbrust e G. Ramadori, "FUNCTIONAL-CHARACTERIZATION OF 2 DIFFERENT KUPFFER CELL-POPULATIONS OF NORMAL RAT-LIVER", Journal of hepatology, 25(4), 1996, pp. 518-528
62. CHEVAILLER A; ARLAUD G; PONARD D; PERNOLLET M; CARRERE F; RENIER G; DROUET M; HUREZ D; GARDAIS J
    C1-INHIBITOR BINDING MONOCLONAL IMMUNOGLOBULINS IN 3 PATIENTS WITH ACQUIRED ANGIONEUROTIC-EDEMA
    Journal of allergy and clinical immunology
    
    A. Chevailler et al., "C1-INHIBITOR BINDING MONOCLONAL IMMUNOGLOBULINS IN 3 PATIENTS WITH ACQUIRED ANGIONEUROTIC-EDEMA", Journal of allergy and clinical immunology, 97(4), 1996, pp. 998-1008
63. CICARDI M; BERETTA A; COLOMBO M; GIOFFRE D; CUGNO M; AGOSTONI A
    RELEVANCE OF LYMPHOPROLIFERATIVE DISORDERS AND OF ANTI-C1 INHIBITOR AUTOANTIBODIES IN ACQUIRED ANGIO-EDEMA
    Clinical and experimental immunology
    
    M. Cicardi et al., "RELEVANCE OF LYMPHOPROLIFERATIVE DISORDERS AND OF ANTI-C1 INHIBITOR AUTOANTIBODIES IN ACQUIRED ANGIO-EDEMA", Clinical and experimental immunology, 106(3), 1996, pp. 475-480
64. MOHR M; POLLOKKOPP B; GOTZE O; BURCHARDI H
    PREOPERATIVE SHORT-TERM PROPHYLAXIS WITH C1 INHIBITOR CONCENTRATE IN 2 PATIENTS WITH HEREDITARY ANGIONEUROTIC-EDEMA
    Anasthesist
    
    M. Mohr et al., "PREOPERATIVE SHORT-TERM PROPHYLAXIS WITH C1 INHIBITOR CONCENTRATE IN 2 PATIENTS WITH HEREDITARY ANGIONEUROTIC-EDEMA", Anasthesist, 45(7), 1996, pp. 626-630
65. GRZELEWSKARZYMOWSKA I; SZMIDT M; ROZNIECKI J
    THE VALUE OF C1 ESTERASE INHIBITOR IN PATIENTS WITH ASPIRIN-SENSITIVEURTICARIA
    Journal of investigational allergology & clinical immunology
    
    I. Grzelewskarzymowska et al., "THE VALUE OF C1 ESTERASE INHIBITOR IN PATIENTS WITH ASPIRIN-SENSITIVEURTICARIA", Journal of investigational allergology & clinical immunology, 5(5), 1995, pp. 272-275
66. DEWAZIERES B; DUPOND JL; HORY B; HUMBERT P; WENDLING D; FEST T
    HEREDITARY ANGIO-EDEMA - AN UNDERESTIMATE D THREATENING DISEASE - A REPORT OF 33 CASES
    Annales de dermatologie et de venereologie
    
    B. Dewazieres et al., "HEREDITARY ANGIO-EDEMA - AN UNDERESTIMATE D THREATENING DISEASE - A REPORT OF 33 CASES", Annales de dermatologie et de venereologie, 122(1-2), 1995, pp. 11-15
67. POULLE M; BURNOUFRADOSEVICH M; BURNOUF T
    LARGE-SCALE PREPARATION OF HIGHLY PURIFIED HUMAN C1-INHIBITOR FOR THERAPEUTIC USE
    Blood coagulation & fibrinolysis
    
    M. Poulle et al., "LARGE-SCALE PREPARATION OF HIGHLY PURIFIED HUMAN C1-INHIBITOR FOR THERAPEUTIC USE", Blood coagulation & fibrinolysis, 5(4), 1994, pp. 543-549
68. NIELSEN EW; JOHANSEN HT; STRAUME B; MOLLNES TE
    EFFECT OF TIME, TEMPERATURE AND ADDITIVES ON A FUNCTIONAL ASSAY OF C1INHIBITOR
    Journal of immunological methods
    
    E.W. Nielsen et al., "EFFECT OF TIME, TEMPERATURE AND ADDITIVES ON A FUNCTIONAL ASSAY OF C1INHIBITOR", Journal of immunological methods, 173(2), 1994, pp. 245-251
69. NURNBERGER W; MICHELMANN I; PETRIK K; HOLTHAUSEN S; WILLERS R; LAUERMANN G; EISELE B; DELVOS U; BURDACH S; GOBEL U
    ACTIVITY OF C1 ESTERASE INHIBITOR IN PATIENTS WITH VASCULAR LEAK SYNDROME AFTER BONE-MARROW TRANSPLANTATION
    Annals of hematology
    
    W. Nurnberger et al., "ACTIVITY OF C1 ESTERASE INHIBITOR IN PATIENTS WITH VASCULAR LEAK SYNDROME AFTER BONE-MARROW TRANSPLANTATION", Annals of hematology, 67(1), 1993, pp. 17-21
70. ZURAW BL
    C1-INHIBITOR DEFICIENCY AND AUTOIMMUNITY
    Immunology and allergy clinics of North America
    
    B.L. Zuraw, "C1-INHIBITOR DEFICIENCY AND AUTOIMMUNITY", Immunology and allergy clinics of North America, 13(2), 1993, pp. 441-457
71. HUMBERT P; DUPOND AS; AGACHE P
    PROTEASE INHIBITOR DEFICIENCIES IN DERMATOLOGY
    Annales de dermatologie et de venereologie
    
    P. Humbert et al., "PROTEASE INHIBITOR DEFICIENCIES IN DERMATOLOGY", Annales de dermatologie et de venereologie, 120(5), 1993, pp. 401-406
72. GUERRERO R; VELASCO F; RODRIGUEZ M; LOPEZ A; ROJAS R; ALVAREZ MA; VILLALBA R; RUBIO V; TORRES A; DELCASTILLO D
    ENDOTOXIN-INDUCED PULMONARY DYSFUNCTION IS PREVENTED BY C1-ESTERASE INHIBITOR
    The Journal of clinical investigation
    
    R. Guerrero et al., "ENDOTOXIN-INDUCED PULMONARY DYSFUNCTION IS PREVENTED BY C1-ESTERASE INHIBITOR", The Journal of clinical investigation, 91(6), 1993, pp. 2754-2760
73. HAERING JM; COMUNALE ME
    CARDIOPULMONARY BYPASS IN HEREDITARY ANGIOEDEMA
    Anesthesiology
    
    J.M. Haering e M.E. Comunale, "CARDIOPULMONARY BYPASS IN HEREDITARY ANGIOEDEMA", Anesthesiology, 79(6), 1993, pp. 1429-1433